- Open
- 1960.00
- High
- 1983.50
- Low
- 1956.50
- Close
- 1963.60
- Change
- +1.50 (0.08%)
- Volume
- 661,923
| 13 Jul 2026 | 07:00:10 | Positive Jemperli data in dMMR/MSI-H rectal cancer |
| 10 Jul 2026 | 11:58:58 | Hansoh positive Phase III results for Riz-Rez |
| 9 Jul 2026 | 15:30:00 | Director/PDMR Shareholding |
| 9 Jul 2026 | 10:00:00 | Directorate change |
| 5 Mar 2026 | 2025 Annual Financial Report | |
| 27 Feb 2025 | 2024 Annual Financial Report | |
| 1 Mar 2024 | 2023 Annual Financial Report |
GSK plc, previously known as GlaxoSmithKline plc, is a multinational biotechnology and pharmaceutical corporation based in London, England, with a worldwide presence.
| 13 Jul 2026 | 07:00:10 | Positive Jemperli data in dMMR/MSI-H rectal cancer |
| 10 Jul 2026 | 11:58:58 | Hansoh positive Phase III results for Riz-Rez |
| 9 Jul 2026 | 15:30:00 | Director/PDMR Shareholding |
| 9 Jul 2026 | 10:00:00 | Directorate change |
| 5 Mar 2026 | 2025 Annual Financial Report | |
| 27 Feb 2025 | 2024 Annual Financial Report | |
| 1 Mar 2024 | 2023 Annual Financial Report |
GSK plc, previously known as GlaxoSmithKline plc, is a multinational biotechnology and pharmaceutical corporation based in London, England, with a worldwide presence.
| 1 Jul 2026 | 15:00:01 | Total Voting Rights |
Lord Balfe has interests in this issuer
| 1 Jul 2026 | 15:00:01 | Total Voting Rights |
Lord Balfe has interests in this issuer
